Ambrose C T
J Exp Med. 1969 Nov 1;130(5):1003-29. doi: 10.1084/jem.130.5.1003.
Two opposite effects of actinomycin D on antibody synthesis have been studied in organ cultures of rabbit lymph node fragments. These cultures were prepared from previously primed rabbits and stimulated with antigen(s) on day 0 to yield a secondary response, whose inductive phase extended to about day 9 and whose productive phase may last for several months in the serum-free medium described here. Concentrations of actinomycin D above 0.01 microM (0.012 microg/ml) produce inhibition of antibody synthesis during both phases of the response. However, antibody synthesis is about 10 times more sensitive to inhibition by this drug when it is added during the inductive phase than during the productive phase. During the latter phase, synthesis is more rapidly terminated as the drug level approaches 10 /microM (12.5 microg/ml). At this level the 50% synthesis time is about 2.8 hr, which is identical with that found when 5-10 microM puromycin is added to the medium of parallel cultures. Transient enhancement of antibody synthesis is frequently produced by a brief exposure to low levels of actinomycin D (generally less than 0.01 microM). Enhancement appears in precise temporal association with actinomycin pulses added for 2 days or less only between days 6 and 16. This apparent enhancement of antibody synthesis resembles the increased enzyme synthesis described by Garren et al. (6) and led to a search for an antibody-inhibitory material (AIM) whose synthesis might be stopped preferentially by low levels of the drug. Stimulated lymph node cultures produce between days 6 and 15 a nondialyzable material which inhibits antibody synthesis during the productive phase of heterologous antigen-antibody culture systems. Just as enhancement with low levels of actinomycin D appears within 2 hr after the drug has been added to cultures, so inhibition occurs within 4 hr of adding AIM to cultures during their productive phase. These observations suggest that AIM is analogous to the translational "repressor" postulated by Garren et al. (6). AIM has relevance in two areas of immunology: (a) it may be the explanation for many examples of antigenic competition, and (b) it may represent a normal control mechanism for the productive phase.
在兔淋巴结片段的器官培养中研究了放线菌素D对抗体合成的两种相反作用。这些培养物取自先前致敏的兔子,并在第0天用抗原刺激以产生二次反应,其诱导期延长至约第9天,并且在本文所述的无血清培养基中其产生期可能持续数月。高于0.01微摩尔/升(0.012微克/毫升)的放线菌素D浓度在反应的两个阶段均抑制抗体合成。然而,当在诱导期添加这种药物时,抗体合成对其抑制的敏感性比在产生期高约10倍。在产生期,随着药物水平接近10微摩尔/升(12.5微克/毫升),合成终止得更快。在此水平下,50%的合成时间约为2.8小时,这与向平行培养物的培养基中添加5-10微摩尔/升嘌呤霉素时发现的时间相同。短暂暴露于低水平的放线菌素D(通常低于0.01微摩尔/升)经常会导致抗体合成的短暂增强。增强仅在第6天至第16天之间与添加2天或更短时间的放线菌素脉冲精确地在时间上相关联。这种明显的抗体合成增强类似于Garren等人(6)描述的酶合成增加,并导致寻找一种抗体抑制物质(AIM),其合成可能会被低水平的药物优先阻断。受刺激的淋巴结培养物在第6天至第15天产生一种不可透析的物质,该物质在异源抗原-抗体培养系统的产生期抑制抗体合成。正如在向培养物中添加低水平放线菌素D后2小时内出现增强一样,在产生期向培养物中添加AIM后4小时内也会出现抑制。这些观察结果表明,AIM类似于Garren等人(6)假设的翻译“阻遏物”。AIM在两个免疫学领域具有相关性:(a)它可能是许多抗原竞争例子的解释,(b)它可能代表产生期的一种正常控制机制。